The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium

[1]  E. Weiderpass,et al.  Incidence of uterine leiomyosarcoma and endometrial stromal sarcoma in Nordic countries: results from NORDCAN and NOCCA databases. , 2012, Maturitas.

[2]  E. Pukkala,et al.  Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas. , 2011, Gynecologic oncology.

[3]  E. Oliva,et al.  Cytogenetic and molecular aberrations in endometrial stromal tumors. , 2011, Human pathology.

[4]  C. la Vecchia,et al.  Metabolic syndrome and endometrial cancer risk. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  T. Rohan,et al.  A Prospective Study of Inflammation Markers and Endometrial Cancer Risk in Postmenopausal Hormone Nonusers , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[6]  F. Clavel-Chapelon,et al.  Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study , 2010, Endocrine-related cancer.

[7]  J. Prat.  FIGO staging for uterine sarcomas , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  Shannon M. Lynch,et al.  Maximizing resources to study an uncommon cancer: E2C2—Epidemiology of Endometrial Cancer Consortium , 2009, Cancer Causes & Control.

[9]  G. Rennert,et al.  The risk of developing uterine sarcoma after tamoxifen use , 2007, International Journal of Gynecologic Cancer.

[10]  J. Olsen,et al.  Relationship of Benign Gynecologic Diseases to Subsequent Risk of Ovarian and Uterine Tumors , 2005, Cancer Epidemiology Biomarkers & Prevention.

[11]  E. Calle,et al.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.

[12]  R. Broaddus,et al.  Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  M. Zhan,et al.  Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. , 2004, Gynecologic oncology.

[14]  M. Sherman,et al.  Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus , 2003, Cancer.

[15]  W. McCluggage,et al.  Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas , 2002, International Journal of Gynecologic Cancer.

[16]  A. Venn,et al.  Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients. , 2001, Gynecologic oncology.

[17]  K. Chang,et al.  Utility of CD10 in Distinguishing between Endometrial Stromal Sarcoma and Uterine Smooth Muscle Tumors: An Immunohistochemical Comparison of 34 Cases , 2001, Modern Pathology.

[18]  H. Adami,et al.  Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden) , 2000, Cancer Causes & Control.

[19]  W. Thompson,et al.  Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus , 1996, Cancer.

[20]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[21]  W. Thompson,et al.  Incidence of histologic types of uterine sarcoma in relation to menstrual and reproductive history , 1991, International journal of cancer.

[22]  S. Schwartz,et al.  Marital status and the incidence of sarcomas of the uterus. , 1990, Cancer research.

[23]  S. Schwartz,et al.  A case—control study of risk factors for sarcomas of the uterus , 1989, Cancer.

[24]  Ivar Heuch,et al.  Reproductive factors and risk of cancer of the uterine corpus: a prospective study. , 1988, Cancer research.

[25]  N. Weiss,et al.  The epidemiology of sarcomas of the uterus. , 1986, Journal of the National Cancer Institute.

[26]  M. Chorváth,et al.  [Uterine Sarcomas - a review]. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[27]  C. Guillemette,et al.  Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. , 2011, The Journal of clinical endocrinology and metabolism.

[28]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.